Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
10.1038/s41574-023-00821-8 3 BeccutiG.BiolettoF.Parasiliti-CaprinoM.BensoA.GhigoE.CicolinA.et al (2024)
Beti C, Stratmann B, Bokman G, et al
Drug Targets 13 , 256263 (2013)
Glucagon-like peptide-1 (GLP-1) agonists, which improve insulin secretion, decrease glucagon secretion, increase satiety (and therefore decrease food intake), and may have beneficial effects on beta-cell function, represent an important addition to treatment options
The withdrawal-period change from week 36 to week 88 was another 5.5% down with continued tirzepatide versus 14.0% up after the placebo switch
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
